Clinical Characteristics and Genetic Markers of Leukemia Patients Without MSI
| Patient No. . | Clinical Stage . | Sex/Age (yr) . | Diagnosis . | Cytogenetics and Molecular Genetics . | Treatment . |
|---|---|---|---|---|---|
| 13 | Diagnosis | M/68 | AML M5 | ND | NT |
| 34 | Diagnosis | F/46 | AML M2 | ND | NT |
| 168 | Diagnosis | F/22 | AML M4 | t (9; 11) (p21/22; q23) | NT |
| 191 | Diagnosis | F/39 | AML M2 | 45, X, t (10; 11) (p12; q13.1), inv (11) (q13.1) | NT |
| 192 | Diagnosis | M/29 | AML M1 | 46, XY, t (10; 11) (p12; q21) | NT |
| 197 | Diagnosis | M/19 | AML M4 | 46, XY | NT |
| 211 | Relapse | F/34 | AML M1 | 46, XX | CT |
| 217 | Diagnosis | M/59 | AML M4 | t (8; 21) (q22; q22) | NT |
| 240 | Diagnosis | F/57 | AML M4 | inv (16) (p13q22) | NT |
| 335 | Diagnosis | M/65 | AML M2 | ND | NT |
| 396 | Diagnosis | F/70 | AML M5 | ND | NT |
| 423 | Diagnosis | M/41 | AML M0 | 46, XY | NT |
| 432 | Diagnosis | M/25 | AML M3 | 46, XY | NT |
| 441 | Diagnosis | M/55 | AML M3 | 46, XY, 15q+, i(17q−) | NT |
| 448 | Relapse | M/64 | AML M2 | 45, X | CT |
| 453 | Diagnosis | M/54 | AML M3 | del (17) (q21; q23) | NT |
| 454 | Diagnosis | F/39 | AML M4 | 45, X, t (8; 21) (q22; q22) | NT |
| 484 | Relapse | M/32 | AML M5 | 46, XY | CT |
| 601 | Diagnosis | M/40 | AML M3 | t (15; 17) (q22; q21) | NT |
| 637 | Diagnosis | F/33 | AML M4 | 46, XY | NT |
| 643 | Diagnosis | M/55 | AML M3 | t (15; 17) (q22; q21) | NT |
| 722 | Diagnosis | F/49 | AML M3 | t (15;17) (q22; q21) | NT |
| 738 | Relapse | M/34 | AML M5 | Complex aberrations with inv (16) (p13;q22) and 47, XY, +22 | CT |
| 743 | Diagnosis | M/36 | AML M4 | inv (16) (p13q22) | NT |
| 774 | Diagnosis | F/23 | AML M3 | ND | NT |
| 860 | Diagnosis | M/38 | AML M2 | 46, XY, del (7) (q22) | NT |
| 106 | Diagnosis | F/22 | T ALL | 46, XX; t(9; 14)(p22; q11) | NT |
| 154 | Diagnosis | M/30 | Pre-B ALL | t (9; 22) (q34; q11) | NT |
| 176 | Diagnosis | M/20 | Pre-B ALL | t(9; 22)(q32; q11) | NT |
| 528 | Diagnosis | M/39 | Pre-B ALL | t (9; 22) (q34; q11) | NT |
| 698 | Relapse | F/35 | Pre-B ALL | ND | CT |
| 699 | Relapse | M/28 | Pre-B ALL | t (2; 9) (p13; p24) | CT |
| 786 | Diagnosis | M/18 | Pre-B ALL | 46, XY | NT |
| VR1 | Diagnosis | M/17 | T ALL | Hyperdiploid karyotype | NT |
| VR3 | Diagnosis | M/23 | B ALL | t(8/14) | NT |
| VR7 | Diagnosis | F/13 | Pre-B ALL | ND | NT |
| Patient No. . | Clinical Stage . | Sex/Age (yr) . | Diagnosis . | Cytogenetics and Molecular Genetics . | Treatment . |
|---|---|---|---|---|---|
| 13 | Diagnosis | M/68 | AML M5 | ND | NT |
| 34 | Diagnosis | F/46 | AML M2 | ND | NT |
| 168 | Diagnosis | F/22 | AML M4 | t (9; 11) (p21/22; q23) | NT |
| 191 | Diagnosis | F/39 | AML M2 | 45, X, t (10; 11) (p12; q13.1), inv (11) (q13.1) | NT |
| 192 | Diagnosis | M/29 | AML M1 | 46, XY, t (10; 11) (p12; q21) | NT |
| 197 | Diagnosis | M/19 | AML M4 | 46, XY | NT |
| 211 | Relapse | F/34 | AML M1 | 46, XX | CT |
| 217 | Diagnosis | M/59 | AML M4 | t (8; 21) (q22; q22) | NT |
| 240 | Diagnosis | F/57 | AML M4 | inv (16) (p13q22) | NT |
| 335 | Diagnosis | M/65 | AML M2 | ND | NT |
| 396 | Diagnosis | F/70 | AML M5 | ND | NT |
| 423 | Diagnosis | M/41 | AML M0 | 46, XY | NT |
| 432 | Diagnosis | M/25 | AML M3 | 46, XY | NT |
| 441 | Diagnosis | M/55 | AML M3 | 46, XY, 15q+, i(17q−) | NT |
| 448 | Relapse | M/64 | AML M2 | 45, X | CT |
| 453 | Diagnosis | M/54 | AML M3 | del (17) (q21; q23) | NT |
| 454 | Diagnosis | F/39 | AML M4 | 45, X, t (8; 21) (q22; q22) | NT |
| 484 | Relapse | M/32 | AML M5 | 46, XY | CT |
| 601 | Diagnosis | M/40 | AML M3 | t (15; 17) (q22; q21) | NT |
| 637 | Diagnosis | F/33 | AML M4 | 46, XY | NT |
| 643 | Diagnosis | M/55 | AML M3 | t (15; 17) (q22; q21) | NT |
| 722 | Diagnosis | F/49 | AML M3 | t (15;17) (q22; q21) | NT |
| 738 | Relapse | M/34 | AML M5 | Complex aberrations with inv (16) (p13;q22) and 47, XY, +22 | CT |
| 743 | Diagnosis | M/36 | AML M4 | inv (16) (p13q22) | NT |
| 774 | Diagnosis | F/23 | AML M3 | ND | NT |
| 860 | Diagnosis | M/38 | AML M2 | 46, XY, del (7) (q22) | NT |
| 106 | Diagnosis | F/22 | T ALL | 46, XX; t(9; 14)(p22; q11) | NT |
| 154 | Diagnosis | M/30 | Pre-B ALL | t (9; 22) (q34; q11) | NT |
| 176 | Diagnosis | M/20 | Pre-B ALL | t(9; 22)(q32; q11) | NT |
| 528 | Diagnosis | M/39 | Pre-B ALL | t (9; 22) (q34; q11) | NT |
| 698 | Relapse | F/35 | Pre-B ALL | ND | CT |
| 699 | Relapse | M/28 | Pre-B ALL | t (2; 9) (p13; p24) | CT |
| 786 | Diagnosis | M/18 | Pre-B ALL | 46, XY | NT |
| VR1 | Diagnosis | M/17 | T ALL | Hyperdiploid karyotype | NT |
| VR3 | Diagnosis | M/23 | B ALL | t(8/14) | NT |
| VR7 | Diagnosis | F/13 | Pre-B ALL | ND | NT |
Abbreviations: M, male; F, female; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CT, chemotherapy; NT, no treatment; ND, not determined.